Skip to main content
. Author manuscript; available in PMC: 2017 Jan 9.
Published in final edited form as: Clin Trials. 2012 Feb 3;9(2):198–203. doi: 10.1177/1740774511434844

Table 2.

Reasons for exclusion by method

Exclusion CR
N (%)
APS
N (%)
Primary hyperglycemia 8 (1.0) 11 (0.6)
Refused 21 (2.5) 21 (1.1)
CNS condition 58 (7.0) 91 (4.9)
Life expectancy less than one year 47 (5.7) 123 (6.6)
Language barrier: unable to procure interpreter services 8 (1.0) 89 (4.8)
Hemoglobin A1c at goal 405 (49.0) 873 (46.6)
Administrative reasons 107 (12.9) 169 (9.0)
Other comorbidities that increase the risk of hypoglycemia with insulin use 81 (9.8) 304 (16.2)
Hemoglobin A1c unreliable 14 (1.7) 11 (0.6)
Severe liver or kidney disease 66 (8.0) 160 (8.6)

CR= Manual Chart Review; APS= Automated Pre-Screening

P= 0.001 for chi-square between methods; percentages do not sum to 1.0 due to rounding error.